AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown."
ENJOY GREECE
We Explore, Find, Check & Propose You for the Truth - Enjoy GREECE - Enjoy EUROPE - Enjoy WORLD
